OPERA Trial Opts for Non-Surgical Treatment for Rectal Cancer
The 38-month follow-up data of the phase 3 OPERA trial showed that non-surgical treatment is feasible for patients with cT2-cT3a-b rectal cancer (RC). In patients who needed surgery, this treatmen...
